Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups

Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups

[...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-01, Vol.71 (1), p.108-108
Hauptverfasser: Magnuson, Elizabeth A., Bonaca, Marc P., Bhatt, Deepak L., Cohen, Marc, Steg, Philippe Gabriel, Storey, Robert F., Braunwald, Eugene, Sabatine, Marc S., Cohen, David J.
Format: Artikel
Sprache:eng
Schlagworte:
Cardiovascular disease
Cost analysis
Disease prevention
Health risk assessment
Heart attacks
Myocardial infarction
Subgroups
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable (
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.10.079